Gene: PSD

5662
EFA6|EFA6A|PSD1|TYL
pleckstrin and Sec7 domain containing
protein-coding
10q24.32
Ensembl:ENSG00000059915 MIM:602327 Vega:OTTHUMG00000018954 UniprotKB:A5PKW4
NC_000010.11
PubMed
CD|OD|ND|AD
23   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.747e-2 (AD)  3.476e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg06700877chr10:104169610PSD3.400e-9Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PDZD40.969
NCS10.964
FBXL160.959
SEPT50.953
RUNDC3A0.949
BAP10.946
JPH30.942
DLG40.941
AGAP30.938
MAP3K100.935

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.753
OR4F29-0.698
SGMS2-0.379
ANXA13-0.372
VRK2-0.36
TFPI2-0.349
CNTF-0.341
KCNJ15-0.336
DTHD1-0.333
KIAA0040-0.329

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
D000082AcetaminophenAcetaminophen affects the expression of PSD mRNA17562736
D000535Aluminum[APP protein modified form binds to Aluminum] which results in decreased expression of PSD mRNA21298039
D000643Ammonium ChlorideAmmonium Chloride affects the expression of PSD mRNA16483693
D001241AspirinAspirin results in increased expression of PSD mRNA11906190
C547126AZM551248AZM551248 results in decreased expression of PSD mRNA22323515
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of PSD mRNA21839799
D004958EstradiolEstradiol results in increased expression of PSD mRNA20068009
C006780bisphenol Abisphenol A affects the expression of PSD mRNA25181051
C584509C646 compoundC646 compound results in decreased expression of PSD mRNA26191083
D019327Copper SulfateCopper Sulfate results in increased expression of PSD mRNA19549813
D003471CuprizoneCuprizone results in decreased expression of PSD mRNA26577399
D003976DiazinonDiazinon results in increased methylation of PSD gene22964155
C492448ICG 001ICG 001 results in decreased expression of PSD mRNA26191083
D007657Ketone BodiesKetone Bodies results in increased expression of PSD mRNA16807920
D007854LeadLead affects the expression of PSD mRNA28903495
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of PSD mRNA22776087
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PSD mRNA"25510870
D010936Plant ExtractsPlant Extracts results in decreased expression of PSD mRNA23557933
C017947sodium arsenitesodium arsenite affects the methylation of PSD gene28589171
C501413tesaglitazartesaglitazar results in decreased expression of PSD mRNA21515302
C009495titanium dioxidetitanium dioxide results in increased expression of PSD mRNA23557971
C057693troglitazonetroglitazone results in decreased expression of PSD mRNA17569031
C057693troglitazonetroglitazone results in decreased expression of PSD mRNA21515302
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of PSD gene25560391

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005086ARF guanyl-nucleotide exchange factor activity-IDA23603394  
GO:0005515protein binding-IPI20339350  
GO:0005543phospholipid binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0007165signal transduction-NAS9417912  
GO:0031175neuron projection development-IEA-  
GO:0032012regulation of ARF protein signal transduction-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0014069postsynaptic density-IEA-  
GO:0032154cleavage furrow-IDA23603394  
GO:0032587ruffle membrane-IDA23603394  
GO:0043197dendritic spine-IEA-  
GO:0098999extrinsic component of postsynaptic endosome membrane-IEA-  
KEGG ID KEGG Term
hsa04144Endocytosis
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
20336176The Role of AMPAR Trafficking Mediated by Neuronal Pentraxins in Cocaine-induced Neuroadaptations. (2009 May 6)Pacchioni AMMol Cell Pharmacol
27894930Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. (2017 Jan)Marco EMPharmacol Biochem Behav
25769285Dendritic remodeling of hippocampal neurons is associated with altered NMDA receptor expression in alcohol dependent rats. (2015 Mar)Staples MCMol Cell Neurosci
22033836Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. (2012 Mar)Parameshwaran KCell Mol Life Sci
23546937Chronic alcoholism-mediated impairment in the medulla oblongata: a mechanism of alcohol-related mortality in traumatic brain injury? (2013)Lai XPCell Biochem Biophys
25601500Deterministic effects after fenestrated endovascular aortic aneurysm repair. (2015 Apr)Kirkwood MLJ Vasc Surg
14749431Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. (2004 Jan 28)Morabito MAJ Neurosci
22548195Kalirin, a key player in synapse formation, is implicated in human diseases. (2012)Mandela PNeural Plast
19557105Cognitive impairment after cerebrovascular stroke: Relationship to vascular risk factors. (2009)Khedr EMNeuropsychiatr Dis Treat
11167288Defective visual field tests in chronic heavy smokers. (2001 Feb)Hepsen IFActa Ophthalmol Scand
24667898Structural reorganization of pyramidal neurons in the medial prefrontal cortex of alcohol dependent rats is associated with altered glial plasticity. (2015)Kim ABrain Struct Funct
20018661Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD. (2010 Jan 5)Thorsen TSProc Natl Acad Sci U S A
24704371Epigenetic upregulation of PSD-95 contributes to the rewarding behavior by morphine conditioning. (2014 Jun 5)Wang ZEur J Pharmacol
7686471The effects of ethanol on EEG activity in males at risk for alcoholism. (1993 Jun)Cohen HLElectroencephalogr Clin Neurophysiol
25145782Ocular and systemic factors associated with glaucoma in chronic kidney disease patients. (2014 Nov)Djordjevic-Jocic JInt Urol Nephrol
17325440Absent post-ischemic increase of blood flowmotion in the cutaneous microcirculation of healthy chronic cigarette smokers. (2007)Rossi MClin Hemorheol Microcirc
23867772Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? (2013 Oct 22)Villalba RMNeuroscience
17481661Glutamate signaling proteins and tyrosine hydroxylase in the locus coeruleus of alcoholics. (2008 Apr)Karolewicz BJ Psychiatr Res
24397780Tolerance to ethanol intoxication after chronic ethanol: role of GluN2A and PSD-95. (2015 Mar)Daut RAAddict Biol
27898427Cocaine Withdrawal Reduces Gamma-Aminobutyric Acid-Ergic Transmission and Gephyrin Expression at Medial Prefrontal Cortex in Cocaine-Conditioned Place-Preference Rats, Which Shows Increased Cocaine Seeking. (2017)Yang WEur Addict Res
25532598Cardiac autonomic changes in middle-aged women: identification based on principal component analysis. (2016 Jul)Trevizani GAClin Physiol Funct Imaging
29089442Extinction of Contextual Cocaine Memories Requires Cav1.2 within D1R-Expressing Cells and Recruits Hippocampal Cav1.2-Dependent Signaling Mechanisms. (2017 Dec 6)Burgdorf CEJ Neurosci
12457264Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunit. (2002 Dec)Loftis JMPsychopharmacology (Berl)